
Kylo Pharmaceuticals Private Limited
About Kylo Pharmaceuticals Private Limited
Data last updated:
Kylo Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24230UR2020PTC011814.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepa Dhiman and Anurag Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1619 Govindpuri Near Holi Ganges, Haridwar, Uttarakhand, India – 249401.
Company details
Contact details
Kylo Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand.
- Registered Address1619 Govindpuri Near Holi Ganges, Haridwar, Uttarakhand, India – 249401
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kylo Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kylo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kylo Pharmaceuticals Private Limited
Kylo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepa Dhiman | Director | 28 Nov 2020 | 5 Years 11 Months | Current |
| Anurag Sharma | Director | 28 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Kylo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kylo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kylo Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kylo Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Anurag Sharma was appointed as Director on 28 Nov 2020.
Frequently asked questions
Kylo Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 November 2020 (6+ years old) and is registered under CIN U24230UR2020PTC011814.
Kylo Pharmaceuticals has 2 current directors:
- Deepa Dhiman - Director
- Anurag Sharma - Director
The latest financial statements of Kylo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Kylo Pharmaceuticals is U24230UR2020PTC011814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kylo Pharmaceuticals was incorporated on 28 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Anurag Sharma was appointed as Director on 28 Nov 2020. Deepa Dhiman was appointed as Director on 28 Nov 2020.
The registered office of Kylo Pharmaceuticals is at 1619 Govindpuri Near Holi Ganges, Haridwar, Uttarakhand, India – 249401.
Kylo Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Kylo Pharmaceuticals can be reached at its registered office: 1619 Govindpuri Near Holi Ganges, Haridwar, Uttarakhand, India – 249401.
Kylo Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttarakhand.

